These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23725154)

  • 1. Associations of IL-10 gene polymorphisms with acute myeloid leukemia in Hunan, China.
    Yao CJ; Du W; Chen HB; Xiao S; Wang CH; Fan ZL
    Asian Pac J Cancer Prev; 2013; 14(4):2439-42. PubMed ID: 23725154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 promoter polymorphisms affect IL-10 production and associate with susceptibility to acute myeloid leukemia.
    Chenjiao Y; Zili F; Haibin C; Ying L; Sheng X; Lihua H; Wei D
    Pharmazie; 2013 Mar; 68(3):201-6. PubMed ID: 23556339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of interleukin-10 gene polymorphisms with acute myeloid leukemia in human (Egypt).
    Rashed R; Shafik RE; Shafik NF; Shafik HE
    J Cancer Res Ther; 2018; 14(5):1083-1086. PubMed ID: 30197353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Associations of IL-6, IFN-γ, TNF-α, IL-10, and TGF-β1 Functional Variants with Acute Myeloid Leukemia in Turkish Patients.
    Nursal AF; Pehlivan M; Sahin HH; Pehlivan S
    Genet Test Mol Biomarkers; 2016 Sep; 20(9):544-51. PubMed ID: 27486989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 polymorphisms associated with susceptibility to acute myeloid leukemia.
    Fei C; Yao XM; Sun Y; Gu XZ; Yu LQ; Lai X
    Genet Mol Res; 2015 Feb; 14(1):925-30. PubMed ID: 25730030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
    Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
    Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDR1 gene polymorphisms and acute myeloid leukemia AML susceptibility in A Moroccan adult population: A case-control study and meta-analysis.
    Kaltoum ABO; Sellama N; Hind D; Yaya K; Mouna L; Asma Q
    Curr Res Transl Med; 2020 Jan; 68(1):29-35. PubMed ID: 31307954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-10 (1082G/A) Polymorphism is Associated with Susceptibility of Acute Myeloid Leukemia Patients in Sudanese Population.
    Sharif OM; Hassan R; Mohammed Basbaeen AA; Mohmed AH; Ibrahim IK
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):1939-1943. PubMed ID: 31350948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter].
    Yang J; Li CR; Li YB; Li RX; Sun LB; Huang HJ; Wang GB
    Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):598-602. PubMed ID: 14744383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of rs62527607 [GT] single nucleotide polymorphism located in BAALC gene in children with acute leukemia using mismatch PCR-RFLP.
    Nadimi M; Rahgozar S; Moafi A; Tavassoli M; Mesrian Tanha H
    Cancer Genet; 2016; 209(7-8):348-53. PubMed ID: 27372260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of IL-10 polymorphisms with hepatitis B virus infection and outcome in Han population.
    Gao L; Chen X; Zhang L; Wu D; Zhao H; Niu J
    Eur J Med Res; 2016 Jun; 21(1):23. PubMed ID: 27245049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
    Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
    Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2B6 gene single nucleotide polymorphisms and leukemia susceptibility.
    Yuan ZH; Liu Q; Zhang Y; Liu HX; Zhao J; Zhu P
    Ann Hematol; 2011 Mar; 90(3):293-9. PubMed ID: 20878158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia.
    Gotoh N; Saitoh T; Takahashi N; Kasamatsu T; Minato Y; Lobna A; Oda T; Hoshino T; Sakura T; Shimizu H; Takizawa M; Handa H; Yokohama A; Tsukamoto N; Murakami H
    Int J Hematol; 2018 Sep; 108(3):246-253. PubMed ID: 29737460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the relationship between polymorphisms of Cyp1A1, GSTM1, GSTT1 genes and the susceptibility to acute leukemia in the general population of Hunan province].
    Liu QX; Chen HC; Liu XF; Cao YF; Zhang J; Liu J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Dec; 26(12):975-9. PubMed ID: 16676594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene polymorphisms of IL-10 and MxA in responders and non-responders to interferon therapy in HCV Egyptian patients genotype 4.
    Shaker OG; Abdel-Rahim MT; Bayoumi ST
    Cell Biochem Biophys; 2015 Mar; 71(2):617-25. PubMed ID: 25239021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of interleukin-10 (-A592C) among oral cancer with squamous cell carcinoma.
    Singh PK; Ahmad MK; Kumar V; Gupta R; Kohli M; Jain A; Mahdi AA; Bogra J; Chandra G
    Arch Oral Biol; 2017 May; 77():18-22. PubMed ID: 28157558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA2 rs2335052 and GATA2 rs78245253 single-nucleotide polymorphisms in Chinese patients with acute myelocytic leukemia.
    Fang F; Xu J; Kang Y; Ren H; Muyey DM; Chen X; Tan Y; Xu Z; Wang H
    Int J Lab Hematol; 2021 Dec; 43(6):1491-1500. PubMed ID: 34374210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia.
    Liu L; Yang L; Mi Y; Wang J; Li J; Zhang Y; Ma X; Qin T; Xu Z; Xiao Z
    Leuk Res; 2011 Aug; 35(8):1020-6. PubMed ID: 21296419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.